b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="Publisher" Owner="NLM">\n        <PMID Version="1">30917714</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1476-4954</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Mar</Month>\n                        <Day>27</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title>\n                <ISOAbbreviation>J. Matern. Fetal. Neonatal. Med.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Factors associated with obtaining results on repeat cell-free DNA testing in samples redrawn due to insufficient fetal fraction.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1-6</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2019.1594190</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate factors associated with obtaining results on repeat cell-free DNA testing for fetal trisomy after an initial sample with insufficient fetal fraction.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">A series of clinical laboratory samples was queried to identify patients with multiple samples drawn for the Harmony<sup>\xc2\xae</sup> prenatal test. Maternal demographics, gestational age, timing of sampling, and repeat test outcome were reviewed. Multivariate logistic regression analysis was used to determine the odds ratio of obtaining a result.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Two thousand nine hundred six unique pregnancies were identified with a sample submitted for repeat testing after an initial test with an insufficient fetal fraction. Overall, 53% obtained a result on the second draw. The odds of obtaining a result were associated with interval time between draws (per day, OR 1.040, 95% CI 1.031-1.051) and maternal weight (per kg, OR 0.988, 95% CI 0.985-0.991) but not maternal age, gestational age at initial draw, IVF status, or twin versus singleton pregnancy.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The probability of obtaining a result with repeat cell-free DNA testing decreases with higher maternal weight and increases with the interval between draws. Waiting longer before collecting a repeat sample increases the probability of obtaining a result but should be considered in the context of the gestational age of the pregnancy and the clinical indication for testing.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>White</LastName>\n                    <ForeName>Karen</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Ariosa Diagnostics Inc., Roche Sequencing Solutions Inc. , San Jose , CA , USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Yunwei</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Ariosa Diagnostics Inc., Roche Sequencing Solutions Inc. , San Jose , CA , USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kunz</LastName>\n                    <ForeName>Liza Hope</ForeName>\n                    <Initials>LH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Ariosa Diagnostics Inc., Roche Sequencing Solutions Inc. , San Jose , CA , USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Schmid</LastName>\n                    <ForeName>Maximilian</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Ariosa Diagnostics Inc., Roche Sequencing Solutions Inc. , San Jose , CA , USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>27</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>J Matern Fetal Neonatal Med</MedlineTA>\n            <NlmUniqueID>101136916</NlmUniqueID>\n            <ISSNLinking>1476-4954</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Cell-free DNA</Keyword>\n            <Keyword MajorTopicYN="N">NIPT</Keyword>\n            <Keyword MajorTopicYN="N">fetal fraction</Keyword>\n            <Keyword MajorTopicYN="N">no-call</Keyword>\n            <Keyword MajorTopicYN="N">noninvasive prenatal testing</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>aheadofprint</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30917714</ArticleId>\n            <ArticleId IdType="doi">10.1080/14767058.2019.1594190</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'